NCT03945708View on ClinicalTrials.gov

Does Whole Blood Adsorber During CPB Reduce Vasoactive Drugs Postoperatively in Endocarditis Patients Undergoing Valve Surgery?

NACompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

May 15, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions

Infective Endocarditis

Interventions

DEVICE

CytoSorb

Addition of a hemofilter to the cardiopulmonary bypass circuit

Trial Locations (1)

Unknown

Sahlgrenska University Hospital, Gothenburg

Sponsors

Collaborators (1)

CytoSorbents, Inc

All Listed Sponsors

collaborator

CytoSorbents, Inc

INDUSTRY

lead

Emma Hansson

OTHER